Conflict of Interest Key Personnel

Furthermore, the University is required to maintain information concerning any significant financial interest disclosed to the University that meets the following three criteria: 

• The significant financial interest was disclosed and is still held by the senior/key personnel;
• The University determines that the significant financial interest is related to funded research or to scholarly and/or educational activities funded under external grants, contracts or cooperative agreements; and
• The University determines that the significant financial interest is a Financial Conflict of Interest (FCOI).

The following personnel have met the above criteria. The information provided is current as of 10/25/23 and is subject to updates, on at least an annual basis and within 60 days of the Institution’s identification of a new FCOI.

• Ahn, Yeon, M.D.

  Title/role:	Team Member
  Name of SFI entity:	RxMP Therapeutics, LLC
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Ahn owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Alencar, Alvaro, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Genetech
  Nature of SFI:	consultant and scientific advisory board member
  Approximate Dollar Amount:	Dr. Alencar received compensation from this company in the amount of $20,000-$100,000.

• Alvarez, Ofelia, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Novartis
  Nature of SFI:	Consultant
  Approximate Dollar Amount:	Dr. Alvarez has received compensation from this company in the amount of $5,000-$9,999.

• Antoni, Michael, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Blue Note Therapeutics
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Antoni has received compensation from this company in the amount of $10,000 - $24,999.

• Ayad, Nagy, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Epigenetix
  Nature of SFI:	Consultant and Equity holder
  Approximate Dollar Amount:	Dr. Ayad owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value..

• Banerjee, Sulagna, Ph.D.

  Title/role:	Principal Investigator and Team Member
  Name of SFI entity:	Minneamrita Therapeutics
  Nature of SFI:	Consultant
  Approximate Dollar Amount:	Dr. Banerjee has received compensation from this company in the amount of $10,000-$20,000.

• Barber, Glen, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	StingInn
  Nature of SFI:	Equity
  Approximate Dollar Amount:	Dr. Barber owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value

• Benedetto, Pasquale, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Novartis
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Benedetto has received compensation from this company in the amount of $5,000-$9,999.

• Bramlett, Helen M., Ph.D.

   

  Title/role:	Co-Investigator
  Name of SFI entity:	InflamaCORE, LLC
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Bramlett owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

    

  Title/role:	Co-Investigator, Team Member
  Name of SFI entity:	Zyversa
  Nature of SFI:	Consulting, advisory board membership, equity
  Approximate Dollar Amount:	Dr. Bramlett's spouse has received compensation from this company in the amount of $5,000-$9,999. Dr. Bramlett owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Capobianco, Anthony, Ph.D.

  Title/role:	Principal Investigator; Study Team Member
  Name of SFI entity:	StemSynergy Therapeutics, Inc.
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Capobianco owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Chen, Zheng-Yi, Ph.D.

  Title/role:	Principal Investigator at Massachusetts Eye and Ear Institute
  Name of SFI entity:	Salubritas Therapeutics, Inc
  Nature of SFI:	Equity interest in a non-publicly traded entity
  Approximate Dollar Amount:	Dr. Chen owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Dakof, Gayle, Ph.D.

  Title/role:	Co-Investigator
  Name of SFI entity:	MDFT International
  Nature of SFI:	Director
  Approximate Dollar Amount:	Dr. Dakof received compensation as salary and travel from this company in the amount of $20,000-100,000. Dr. Dakof's spouse, Dr. Liddle, also has a professional relationship with this company. He received between $5,000-9,999 as the Chairman, Board of Directors, and consultant for MDT International.

• Davis, Janet, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Allergan
  Nature of SFI:	Consulting; Advisory Board
  Approximate Dollar Amount:	Dr. Davis received compensation from this company in the amount of $5,000-9,999.

• de Rivero Vaccari, Juan Pablo, Ph.D.

  Title/role:	Team member
  Name of SFI entity:	Zyversa
  Nature of SFI:	Equity
  Approximate Dollar Amount:	Dr. de Rivero Vaccari owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

   

  Title/role:	Team Member
  Name of SFI entity:	InflamaCORE, LLC
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. de Rivero Vaccari owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Dhar, Shanta, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Partikula LLC
  Nature of SFI:	Consultant; Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Dhar has received compensation in the amount of $20,000 - $100,000 from this company. In addition, Dr. Dhar owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Dietrich, Dalton, Ph.D.

   

  Title/role:	Principal Investigator
  Name of SFI entity:	InflamaCORE, LLC
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Dietrich owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

   

  Title/role:	Principal Investigator
  Name of SFI entity:	Zyversa
  Nature of SFI:	Consulting; advisory board membership, equity
  Approximate Dollar Amount:	Dr. Dietrich has received compensation from this company in the amount of $5,000-$9,999. Dr. Dietrich owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Dobliecki-Lewis, Suzanne, M.D.

  Title/role:	Team member
  Name of SFI entity:	Gilead Pharmaceuticals
  Nature of SFI:	Consultant
  Approximate Dollar Amount:	Dr. Dobliecki-Lewis has received compensation in the amount of $0 - $10,000 from this company.

• Dominguez-Bendala, Juan, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Ophysio, Inc
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Dominguez-Bendala owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Doss, Brian, Ph.D

  Title/role:	Principal Investigator
  Name of SFI entity:	Our Relationship, LLC
  Nature of SFI:	Equity
  Approximate Dollar Amount:	Dr. Doss owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

   

• Ehrenreich-May, Jill, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Kinark Child and Family Services
  Nature of SFI:	Teaching, training, Lecturing or speaking; Sponsored or reimbursed travel
  Approximate Dollar Amount:	Dr. Ehrenreich-May received compensation from this company in the amount of $10,000-$19,999.

• Fraker, Christopher, Ph.D.

  Title/role:	Principle Investigator and Team Member
  Name of SFI entity:	Ophysio, Inc
  Nature of SFI:	Principal Investigator and Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Fraker owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Franzmann, Elizabeth, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Vigilant Biosciences
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Franzmann owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Fridling, Nicole

  Title/role:	Team Member
  Name of SFI entity:	Talkspace, LLC
  Nature of SFI:	Compensation
  Approximate Dollar Amount:	Ms. Fridling received compensation from this company in the amount of $20,000-$100,000.

• Galvin, James MD, MPH

  Title/role:	Principal Investigator
  Name of SFI entity:	Washington University School of Medicine; New York University Langone Medical Center
  Nature of SFI:	Royalties received as Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Galvin received royalties in the amount of $10,000-40,000.

• Gilboa, Eli, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Sebastian Biopharma
  Nature of SFI:	Equity Ownership
  Approximate Dollar Amount:	Dr. Gilboa owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Goldberger, Jeffrey, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Gold-T Tech, Inc.
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Goldberger owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Gustafson, David, Ph.D.

  Title/role:	Sub-Contractor
  Name of SFI entity:	D. Gustafson & Associates
  Nature of SFI:	Sole Ownership; Consultant
  Approximate Dollar Amount:	Dr. Gustafson received compensation as salary from this company in the amount of $20,000-100,000. He is also a consultant for this company.

• Harbour, James, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Washington University; Castle Biosciences
  Nature of SFI:	Royalties received as Inventor of Intellectual Property; Consultant
  Approximate Dollar Amount:	Dr. Harbour received royalties in the amount of $20,000-40,000; compensation from this company in the amount of $10,000-20,000.

• Hare, Joshua, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Vestion
  Nature of SFI:	Equity Ownership
  Approximate Dollar Amount:	Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $20,000 - $100,000.

   

  Title/role:	Principal Investigator
  Name of SFI entity:	Biscayne Pharmaceuticals
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

   

  Title/role:	Principal Investigator
  Name of SFI entity:	Longeveron, LLC
  Nature of SFI:	Equity Ownership; Chief Scientific Officer
  Approximate Dollar Amount:	Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $250,000 - $299,999

• Harvey, Philip, Ph.D.

  Title/role:	Team Member
  Name of SFI entity:	i-Function, Inc.
  Nature of SFI:	Equity Ownership; Chief Scientific Officer
  Approximate Dollar Amount:	Dr. Harvey owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Hoffman, James, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Celgene
  Nature of SFI:	consultant or scientific advisory board member and teaching, training, lecturing or speaking
  Approximate Dollar Amount:	Dr. Hoffman received compensation from this company in the amount of $20,000-$100,000.

• Jy, Wenche, Ph.D.

  Title/role:	Team Member
  Name of SFI entity:	RxMP Therapeutics, LLC
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Jy owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Kasahara, Noriyuki, M.D., Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Tocagen, Inc.
  Nature of SFI:	Equity Ownership
  Approximate Dollar Amount:	Dr. Kasahara owns equity in this company, in the amount of $700,000-$749,999.

• Keane, Robert, Ph.D.

  Title/role:	Team member
  Name of SFI entity:	Zyversa
  Nature of SFI:	Equity
  Approximate Dollar Amount:	Dr. Keane owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

   

  Title/role:	Team Member
  Name of SFI entity:	InflamaCORE, LLC
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Keane owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• King, Roderick, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Florida Institute for Health Innovation (FIHI)
  Nature of SFI:	Chief Executive Officer
  Approximate Dollar Amount:	Dr. King has received less than $9,999 in compensation from FIHI.

• Levitt, Roy C., M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Adolore Biotherapeutics
  Nature of SFI:	Board of Directors, Intellectual Property
  Approximate Dollar Amount:	Dr. Levitt owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Levy, Robert, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Heat BiologicsHeat Biologics
  Nature of SFI:	Equity ownership; consultant/advisory board member
  Approximate Dollar Amount:	Dr. Levy owns equity in this publicly traded company in the range of $10,000 -19,999, and has received compensation from this company in the amount of $5,000-9,999.

   

  Title/role:	Principal Investigator
  Name of SFI entity:	Allergan
  Nature of SFI:	Consultant
  Approximate Dollar Amount:	Dr. Levy received compensation from this company in the amount of $5,000-9,999.

• Larsson, Hans, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	VentricPharm
  Nature of SFI:	Equity ownership
  Approximate Dollar Amount:	Dr. Larsson owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Liddle, Howard, E.D.D.

  Title/role:	Principal Investigator; Study Team Member
  Name of SFI entity:	MDFT International
  Nature of SFI:	Chairman; Board of Directors; Consultant
  Approximate Dollar Amount:	Dr. Liddle received compensation as salary from this company in the amount of $5,000-9,999. Dr. Liddle's spouse, Dr. Dakof, also has a professional relationship with this company. She received between $20,000-100,000 as the Director of MDFT International.

• Liu, Zhao-Jun

  Title/role:	PI
  Name of SFI entity:	Ambulero, Inc
  Nature of SFI:	Equity ownership; Intellectual Property
  Approximate Dollar Amount:	Dr. Liu owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. Dr. Liu received royalties for the IP in the amount of $10,000-$20,000.

• Mahtani, Reshma, D.O.

  Title/role:	Team Member
  Name of SFI entity:	Novartis
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Mahtani has received compensation from this company in the amount of $10,000-24,999.

   

  Title/role:	Team Member
  Name of SFI entity:	AstraZeneca
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Mahtani has received compensation from this company in the amount of $5,000-9,999.

   

  Title/role:	Team Member
  Name of SFI entity:	Pfizer
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Mahtani has received compensation from this company in the amount of $10,000-24,999.

   

   

• McCarthy, Micheline, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Novartis
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. McCarthy has received compensation from this company in the amount of $5,000-$9,999.

• Penedo, Frank, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Blue Note Therapeutics
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Penedo has received compensation from this company in the amount of $10,000 - $24,999.

• Petrova, Mariya, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Pear Therapeutics
  Nature of SFI:	Salary not from the awardee Institution
  Approximate Dollar Amount:	Dr. Petrova has received compensation from this company in the amount of $250,000 - $299,999.

• Rajguru, Suhrud

  Title/role:	PI
  Name of SFI entity:	Restor-Ear, LLC
  Nature of SFI:	Equity
  Approximate Dollar Amount:	Dr. Rajguru owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

   

• Rammohan, Kottil, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Novartis
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Rammohan has received compensation from this company in the amount of $5,000-$9,999.

   

  Title/role:	Team Member
  Name of SFI entity:	Genzyme
  Nature of SFI:	Consultant and Advisory Board Member
  Approximate Dollar Amount:	Dr. Rammohan has received compensation from this company in the amount of $5,000-$9,999.

• Ricordi, Camillo, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Ophysio, Inc
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property; Advisory Board
  Approximate Dollar Amount:	Dr. Ricordi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Robbins, David, Ph.D.

  Title/role:	Principal Investigator/Team Member
  Name of SFI entity:	StemSynergy Therapeutics
  Nature of SFI:	Equity Ownership
  Approximate Dollar Amount:	Dr. Robbins owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Saluja, Ashok, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Minneamrita Therapeutics
  Nature of SFI:	Equity; Inventor of Intellectual Property
  Approximate Dollar Amount:	Dr. Saluja owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Schüle, Rebecca, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	ViaGenetics, LLC
  Nature of SFI:	Consultant
  Approximate Dollar Amount:	Dr. Schüle has received compensation in the amount of $0 - $10,000 from this company.

• Shousha, Mohammad Abou, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Resolve Ophthalmics, LLC
  Nature of SFI:	Equity Ownership
  Approximate Dollar Amount:	Dr. Abou Shousha owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Slomovitz, Brain, M.D.

  Title/role:	Team member
  Name of SFI entity:	Gilead Pharmaceuticals
  Nature of SFI:	Consultant
  Approximate Dollar Amount:	Dr. Dobliecki-Lewis has received compensation in the amount of $0 - $10,000 from this company.

• Stock, Aaron

  Title/role:	Team Member
  Name of SFI entity:	Sernova
  Nature of SFI:	Intellectual Property
  Approximate Dollar Amount:	Mr. Stock has received $5,000 - $10,000 from the company.

   

• Tector, Joseph, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Makana Therapeutics
  Nature of SFI:	Equity ownership; Compensation; Intellectual Property
  Approximate Dollar Amount:	Dr. Tector owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. Dr. Tector received compensation from this company in the amount of $20,000-$100,000.

• Tomei, Alice, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Sernova
  Nature of SFI:	Intellectual Property
  Approximate Dollar Amount:	Dr. Tomei has received $5,000 - $10,000 from the company

• Velazquez, Omaida

  Title/role:	PI
  Name of SFI entity:	Ambulero, Inc
  Nature of SFI:	Equity ownership; Intellectual Property
  Approximate Dollar Amount:	Dr. Velazquez owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. Dr. Velazquez received royalties for the IP in the amount of $10,000-$20,000.

• Webster, Keith, Ph.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	Integene International
  Nature of SFI:	Equity Ownership; Inventor of Intellectual Property; Board of Directors
  Approximate Dollar Amount:	Dr. Webster owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Yoo, Sonia, M.D.

  Title/role:	Team Member
  Name of SFI entity:	Resolve Ophthalmics, LLC
  Nature of SFI:	Equity Ownership
  Approximate Dollar Amount:	Dr. Yoo owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

• Züchner, Stephan, M.D.

  Title/role:	Principal Investigator
  Name of SFI entity:	ViaGenetics, LLC
  Nature of SFI:	Equity Ownership; Board of Directors
  Approximate Dollar Amount:	Dr. Dr. Züchner owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.